Congenital Heart

This Congenital Heart Disease channel includes news and new technology to diagnose, treat and manage congenital heart disease. This includes transposed vessels, tetralogy of Fallot, pediatric cardiomyopathy, pulmonary heart valves, pulmonary atresia, patent foramen ovale (PFO), atrial septal defect (ASD) and ventricular septal defect (VSD).

St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch

Technology | Structural Heart Occluders | November 02, 2016

St. Jude Medical Announces FDA Approval and U.S. Launch of Amplatzer PFO Occluder

November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and...

CHOP, Children's Hospital of Philadelphia, prenatal heart surgery, tumor removal, intrapericardial teratoma

Tucker Roussin, 3, is the first survivor of fetal surgery for a life-threatening tumor connected to his heart. Fetal medicine experts at Children's Hospital of Philadelphia successfully removed this tumor. Credit: Children’s Hospital of Philadelphia.

News | Congenital Heart | October 28, 2016

Fetal Surgery Successfully Removes Life-Threatening Tumor Connected to Heart

October 28, 2016 — For the first time, fetal medicine experts have performed prenatal heart surgery to remove a life-...

St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS

News | Congenital Heart | October 19, 2016

St. Jude Medical Announces New Clinical Trial to Treat Congenital Heart Defects

October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional...

Xeltis bioabsorbable valve implant, two-year data, EACTS 2016

News | Heart Valve Technology | October 06, 2016

Two-Year Xeltis Bioabsorbable Valve Data Shows Positive Functionality

October 6, 2016 — Xeltis announced this week that patients implanted with its bioabsorbable cardiovascular conduit...

Xeltis bioabsorbable pulmonary heart valve, Xplore-I clinical feasibility study, first pediatric implants, EACTS 2016

News | Heart Valve Technology | October 04, 2016

First Bioresorbable Heart Valves Implanted to Enable Cardiovascular Restoration

October 4, 2016 — Xeltis recently announced that three pediatric patients have been successfully implanted with the...

Videos | Congenital Heart | October 04, 2016

VIDEO: How the Xeltis Bioresorbable Pulmonary Valve Works

This video, provided by Xeltis, demonstrates the world’s first bioresorbable heart valve enabling cardiovascular...

congenital heart defects, CHD, risk factors, genes, University of California Irvine research

News | Congenital Heart | September 09, 2016

Risk Factors for Congenital Heart Defects May Lie Both Inside and Outside the Heart

September 9, 2016 — New research published Sept. 8 in the Open Access journal PLOS Biology reports the role of genes in...

Xeltis bioabsorbable aortic conduit, endogenous tissue restoration, ETR, preclinical data, ISACB 2016

News | Heart Valve Technology | September 09, 2016

Bioresorbable Pulmonary Valve Replacement May Enable Cardiovascular Regeneration

September 9, 2016 — Six-month preclinical data from trials of a Xeltis bioabsorbable aortic conduit were presented at...

ClearFlow, PleuraFlow System, pediatric patients, cardiothoracic surgery

News | Cardiovascular Surgery | August 08, 2016

ClearFlow Launches FDA-Cleared PleuraFlow System for Pediatric Cardiothoracic Surgery

August 8, 2016 — ClearFlow Inc. announced in late July that its PleuraFlow Active Clearance Technology is now available...

ASE, SCCT, SCMR, guideline, multimodality imaging, transposition of the great arteries, TGA

News | Congenital Heart | July 20, 2016

New Guideline Addresses Multimodality Imaging for Complex Childhood Heart Disease

July 20, 2016 — At the end of June, experts from three different medical societies released a new guideline to help...

Dictum Health, telehealth study, IDM100 tablet, neonate cardiology, in-home monitoring

Technology | Telecardiology | July 19, 2016

Dictum Health Initiates Telehealth Study for Neonate Cardiology

July 19, 2016 — Dictum Health Inc. announced the launch of a post-U.S. Food and Drug Administration (FDA)-approval...

Cormatrix Cardiovascular, Tyke ECM, extracellular matrix, neonates and infants

News | Congenital Heart | June 30, 2016

CorMatrix Cardiovascular Treats First Patients with Tyke Product for Neonates and Infants

June 30, 2016 — CorMatrix Cardiovascular Inc. announced the treatment of the first patients using its CorMatrix Tyke, a...

BHF, Reflections of Research image competition, U.K., 4-D MRI, heart blood flow

This image shows blood flow within the main pumping chambers – the ventricles – on both sides of the heart and the vessels leaving the heart. The blue flow is blood that needs oxygen and is travelling to the lungs. The red flow is blood that has been through the lungs and received oxygen. Victoria Stoll of the University of Oxford is using this type of imaging to look at the blood flow within the hearts of people with heart failure, whose hearts are not pumping effectively.

News | Cardiac Imaging | June 24, 2016

Beating Heart Frozen in Time Wins U.K. Image Competition

June 24, 2016 — The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image...